Showing results (1781-1790 of 1,891) with videos related to
Sort By:
Pageof 190
JMIR Research Protocols|March 22, 2024
Telehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods StudyMarie-Pascale Pomey, Enora Le Roux, Nathalie Nadon, et al.Plos One|May 5, 2023
Adolescent anxiety and pain problems: A joint, genome-wide investigation and pathway-based analysisSara Mascheretti, Diego Forni, Valentina Lampis, et al.Harm Reduction Journal|May 2, 2026
Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugsRob J Fredericksen, Adams Sibley, Kathryn E Lancaster, et al.Journal of Clinical Pharmacology|December 3, 2014
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenibA Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, et al.Lancet (London, England)|May 22, 2012
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialGerald S Falchook, Georgina V Long, Razelle Kurzrock, et al.Journal of Neurotrauma|June 29, 2022
Post-Concussion Symptoms Rule: Derivation and Validation of a Clinical Decision Rule for Early Prediction of Persistent Symptoms after a Mild Traumatic Brain InjuryNatalie Le Sage, Jean-Marc Chauny, Simon Berthelot, et al.Journal of Medicinal Chemistry|February 3, 2006
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin KSheldon N Crane, W Cameron Black, James T Palmer, et al.American Journal of Human Genetics|June 2, 2015
Recessive osteogenesis imperfecta caused by missense mutations in SPARCRoberto Mendoza-Londono, Somayyeh Fahiminiya, Jacek Majewski, et al.Cell Death and Differentiation|March 10, 2007
A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistanceN Gueven, O J Becherel, O Howe, et al.Stem Cell Reports|September 23, 2022
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's diseaseJanelle Drouin-Ouellet, Emilie M Legault, Fredrik Nilsson, et al.Pageof 190